Founded in 1956, Fuwai Hospital of the Chinese Academy of Medical Sciences is the world's largest heart disease diagnosis and treatment center, a well-known cardiovascular talent training base in China, and a specialized cardiovascular hospital integrating medical treatment, teaching, scientific research and prevention
Founded in 1956 and located at No. 167, Beilishi Road, Xicheng District, Beijing, Fuwai Hospital of the Chinese Academy of Medical Sciences is a tertiary first-class cardiovascular disease specialized hospital integrating medical treatment, teaching, scientific research and prevention, as well as the location of the National Center for Cardiovascular Diseases, the State Key Laboratory of Cardiovascular Diseases, and the National Clinical Research Center for Cardiovascular Diseases.
The total land area of the hospital is 55,300 square meters, and the existing total construction area is 157,000 square meters. At present, there are 3,154 full-time employees and 336 full and associate professors. It has 3 clinical management committees of internal medicine, surgery and imaging, 22 clinical diagnosis and treatment centers and departments for cardiovascular diseases, 11 scientific research departments and key laboratories, 10 medical and technical departments, 23 administrative party and mass offices, 41 wards, 28 operating rooms, 5 hybrid operating rooms, 13 catheterization laboratories, and 1,238 actual open beds. The hospital is equipped with medical and scientific research equipment that is in line with the world, such as angiography machine, dual-source CT, nuclear magnetic resonance, PET-CT, etc.
The hospital is the world's largest heart disease diagnosis and treatment center, and is well-known at home and abroad for the diagnosis and treatment of various complex, difficult and severe cardiovascular diseases. In 2015, there were 646662 outpatient visits, 27,157 emergency visits, 56,938 inpatient admissions, 13,755 cardiac surgeries, 41,732 cardiac interventional cases, and 73 heart transplants. The hospital also continues to rank first in the field of cardiovascular disease treatment in China with a series of technical qualities such as the mortality rate of simple coronary artery bypass grafting has remained below 1% for 8 consecutive years, the average mortality rate of complex congenital heart disease with a malformation degree exceeding that of Law IV is 2.6%, the 5-year survival rate of heart transplantation is 89%, and the PCI surgical indicators have always maintained a high international level.
The hospital has one of the largest clinical centers engaged in the diagnosis and treatment of cardiovascular diseases in the country and even in the world.
At present, the Coronary Heart Disease Center is a large-scale clinical institution specializing in the research and diagnosis and treatment of coronary artery and coronary heart disease in China, and has carried out new technologies such as the first two transcatheter aortic valve implantation in China, and has now become a well-known first-class percutaneous coronary intervention (PCI) and transradial PCI (TRI) treatment center in the world. The arrhythmia center is a center specializing in cardiac electrophysiological examination, catheter radiofrequency ablation and implantable pacemaker treatment in China, and has carried out new technologies such as pacemaker implantation with home monitoring function, the world's first "pacemaker implantation that can accept MRI examination", and individualized step ablation of atrial fibrillation. The Hypertension Center is in an international advanced position in the differential diagnosis of secondary hypertension, and has carried out new technologies such as transcatheter radiofrequency ablation and renal sympathetic nerve removal for the treatment of refractory hypertension, and is the largest peripheral vascular disease intervention center in China.
Adult Surgery Centers are all over the worldcompareIt is one of the largest adult cardiac surgery centers that treats various valvular heart diseases, coronary heart diseases, and arrhythmias. Heart transplantation and ventricular mechanical assistance have become the conventional treatment methods for the surgical treatment of acute and advanced heart disease, with an average of more than 50 heart transplants per year, which is the annual number of single-center heart transplantation cases in ChinacompareIn many hospitals, the long-term survival rate of patients is higher than the world average. The Pediatric Surgery Center is the world's largest congenital heart disease treatment center, and has carried out various surgeries such as tetralogy of Fallot, complete transposition of the great arteries, pulmonary atresia, right ventricular double outlets, open-heart surgery without allogeneic blood transfusion for complex congenital heart disease, hemiventricular correction of complex corrective transposition of the aorta, mitral valve replacement of the autologous pulmonary valve (ROSS II surgery), and bidirectional Glenn surgery. The success rate of new surgical technologies and surgical applications such as double arterial root transfer surgery (DRT surgery) and hybrid technology has entered the advanced ranks at home and abroad. The Vascular Surgery Center is the world's largest aortic surgery center, which has carried out a large number of difficult surgeries such as aortic arch replacement, elephant trunk surgery, one-stop compound technology for complex aortic arch lesions, room temperature non-cardiopulmonary bypass total thoracic and abdominal aortic replacement, and spherical stent expansion for aortic coarctation lesions, and is at the international advanced level in the surgical treatment of aortic aneurysm and aortic dissection.
The hospital has also been undertaking a large number of national cadres health care and foreign guest medical treatment tasks, and has been highly praised by party and state leaders and well-known figures at home and abroad for many times.
The hospital adheres to the development direction of paying equal attention to medical scientific research, and is an important national base for scientific research on cardiovascular diseases in China. Now it has 2 State Key Laboratories (State Key Laboratory of Cardiovascular Diseases and National Clinical Research Center for Cardiovascular Diseases), 2 Ministerial Key Laboratories (Key Laboratory of Regenerative Medicine for Cardiovascular Diseases of the Ministry of Health, Key Laboratory of Clinical Research on Cardiovascular Drugs of the Ministry of Health), 2 Key Laboratories of Beijing (Beijing Key Laboratory of Preclinical Research and Evaluation of Cardiovascular Implant Materials, Beijing Key Laboratory of Molecular Diagnosis of Cardiovascular Diseases). It provides a strong scientific research and technology platform for the clinical diagnosis, treatment and prevention of cardiovascular diseases; It has built a hospital-network hospital-community cardiovascular disease prevention and treatment platform, cardiovascular clinical data follow-up and analysis information platform, cardiovascular biological resource library sharing platform, China Cardiovascular Disease Molecular Diagnosis Center, cardiovascular implant materials research and development platform and other high-level medical research platforms and new mechanisms of central laboratories, serving domestic and foreign countries with an open platform. In recent years, the hospital has presided over most of the key research projects since the "Seventh Five-Year Plan" and major projects such as "973", "863", "Eleventh Five-Year Plan" and "Twelfth Five-Year Plan", and has obtained 1,385 scientific research projects. In the past ten years, the hospital has won 11 national science and technology progress awards and 54 provincial and ministerial scientific research awards. He has undertaken 306 national scientific research projects and 64 provincial and ministerial scientific research projects. Since 2010, he has published 1215 SCI articles (2 articles with SCI scores above 40), among which many academic articles have been published in international authoritative journals such as New England, The Lancet, and Circulation.
The hospital strengthens the prevention and health promotion of cardiovascular diseases, and actively plays the role of a "national team" in the field of cardiovascular prevention and treatment. The hospital has built a nationwide community prevention and treatment network for hypertension, formed a prevention and control network of more than 2,600 community health service centers (accounting for 1/10 of the country's community institutions) covering 40 counties and district-level units in 25 provinces, municipalities and autonomous regions, expanded the management of 3 million patients, and trained a team of 25,000 grassroots physicians to promote the promotion and popularization of standardized treatment techniques for hypertension. The hospital cooperates with Xicheng District, Haidian District, Fengtai District and Capital Airport Hospital of Beijing, and adopts two cooperation methods: two-way referral and health management, specialist training and technology output, so that the "big doctors" of large hospitals can enter the community, train and guide community doctors in the prevention and treatment of cardiovascular diseases, and form a "pre-screening base", "post-treatment base" and "health education base". The hospital has actively built a national cardiovascular disease consultation platform, and published the "Guidelines for the Prevention and Treatment of Hypertension in China", "Guidelines for the Prevention and Treatment of Dyslipidemia in Adults in China" and "Report on Cardiovascular Diseases in China", which has made significant contributions to the study of the epidemic trends, prevention strategies and measures of cardiovascular diseases and their risk factors in China.
The hospital is a national training base for famous cardiovascular talents in China, and enjoys the reputation of "Whampoa Military Academy" in the cardiovascular field. The hospital has 336 senior professional and technical personnel. Among them, there are 4 high-level talents of the Chinese Academy of Engineering, 15 national, provincial and ministerial experts, 54 people enjoying special government allowances, 1 "973" chief scientist, 3 talents introduced by the National Thousand Talents Program, 2 Changjiang Scholars Distinguished Professors of the Ministry of Education, 3 winners of the National Science Fund for Distinguished Young Scholars, 5 candidates for the "New Century Millions of Talents Project", 3 candidates for the "National Millions of Talents Project", 3 candidates for the "National Millions of Talents Project", 3 young people (Organization Department of the CPC Central Committee), and 2 innovative talents of the Ministry of Science and Technology. 1 innovation team of the Ministry of Science and Technology, and 1 Changjiang Scholar innovation team of the Ministry of Education. There are seven key disciplines of the Ministry of Education, including internal medicine (cardiovascular disease), surgery (thoracic and cardiac surgery), imaging medicine and nuclear medicine, anesthesiology, genetics, pathology and pathophysiology, biochemistry and molecular biology. At present, the hospital has 77 doctoral supervisors, 89 master's supervisors, 7 doctoral programs, 7 master's programs, 2 national continuing medical education bases, and 2 tertiary discipline specialist training bases. In terms of clinical teaching, the hospital has 310 students, including 145 doctoral students and 165 master's students. In terms of continuing education, the hospital has 465 trainees, and has trained a large number of professional and technical personnel for the country. From 1970 to mid-2015, 60% of the directors of the National Heart Center studied in Fuwai Hospital, and the hospital exported about 500 professional and technical backbones of cardiovascular diseases, and sent cardiac surgery directors to 40 heart centers in various provinces and cities across the country, which greatly improved the overall level of cardiovascular disease treatment in China.
The hospital has a wide international academic influence. It has established close cooperation and exchange relations with world-renowned universities and international academic research institutions such as the National Heart, Lung, and Blood Institute, the University of Oxford, Yale University, and the Cleveland Heart Center, and has hired more than a dozen top experts with high reputation in the global cardiovascular field as honorary professors. The hospital has also cooperated with Canada, Germany, Japan, Australia and the World Health Organization to carry out research projects, and has made important contributions to enhancing China's status in the international field of cardiovascular diseases.
In recent years, in accordance with the requirements of the new medical reform, the hospital has carried out reforms such as the "dual-track system of the director of the medical ward under the leadership of the hospital and the director of the discipline development center", providing high-quality, safe and convenient medical services for patients with cardiovascular diseases. The hospital has achieved excellent results in the previous hospital management activities of the Ministry of Health and the Beijing Municipal Health Bureau. The hospital has been awarded the title of civilized unit of the capital health system for many times. It has also cultivated a large number of "Fuwai" elites, such as the national model of dedication and dedication, the national model worker, the winner of the Bethune Medal, the advanced worker of the national medical and health system, the health guard of the capital, and the good doctor of China, which has won a good social reputation for the hospital.
In August 2010, the National Center for Cardiovascular Diseases, which settled in Fuwai Hospital, was officially announced. In October 2013, the main leaders of the National Center for Cardiovascular Diseases were appointed, and the center entered into substantive operation. Hospitals are facing unprecedented opportunities for growth. The hospital will continue to adhere to the core concept of "guarding health with 'heart'", follow the "Fuwai" spirit of "dedication, benevolence, truth-seeking, and climbing", take patients as the center, innovate key medical technologies, strengthen the prevention and treatment of cardiovascular diseases, formulate treatment and prevention guidelines and standards suitable for China's national conditions and patient characteristics, cultivate qualified and excellent cardiovascular talents, and strive to build a comprehensive national center for the dissemination, production, transformation and application of cardiovascular medical technology knowledge!
